New cardiac rehabilitation treatment for ischemic heart disease
A New Cardiac Rehabilitation Treatment in the Application of Ischemic Heart Disease: a Prospective, Randomized Controlled Clinical Study
NA · Shanghai 10th People's Hospital · NCT06681506
This study is testing a new heart rehab program that combines breathing exercises, exercise therapy, and shock wave treatment to see if it helps people with ischemic heart disease more than the usual rehab methods.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Shanghai 10th People's Hospital (other) |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Trial ID | NCT06681506 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of a novel cardiac rehabilitation therapy that includes early respiratory rehabilitation, exercise therapy, and extracorporeal shock wave treatment for patients with ischemic heart disease. It compares this new approach to traditional cardiac rehabilitation methods, focusing on patient compliance and outcomes. Participants will receive either the new therapy combined with standard drug treatment or traditional rehabilitation methods over a treatment period of 1 to 3 months, followed by a 6-month evaluation of their heart health.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 85 diagnosed with ischemic heart disease who require cardiac rehabilitation.
Not a fit: Patients with acute respiratory distress syndrome, uncontrolled pulmonary infections, or severe arrhythmias may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve recovery and quality of life for patients with ischemic heart disease.
How similar studies have performed: Other studies have shown promise with similar rehabilitation approaches, but this specific combination of therapies is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged between 18 and 85 years old * Female subjects no pregnancy * The main admission diagnosis of ischemic heart disease (coronary heart disease, myocardial infarction, ischemic heart failure, etc.) * The need for cardiac rehabilitation treatment Exclusion Criteria: * acute respiratory distress syndrome (ARDS); * acute episode of COPD; * uncontrolled pulmonary infection; * acute heart failure; acute pulmonary embolism; * acute myocarditis/pericarditis; * severe arrhythmia (degree II or III atrioventricular block, atrial flutter, or atrial fibrillation); * sternotomy, rib fracture, thoracic deformity, or other neurological diseases that may affect respiratory muscles
Where this trial is running
Shanghai, Shanghai Municipality
- Department of Cardiology, Shanghai Tenth People's Hospital — Shanghai, Shanghai Municipality, China (RECRUITING)
Study contacts
- Study coordinator: liujing liu, MD, PhD
- Email: liuweijing98@sina.com
- Phone: +86 18917684041
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Ischemic Heart Disease, Cardiac Rehabilitation, coronary atherosclerotic cardiopathy, Cardiac Shock Wave Therapy, exercise rehabilitation, cardiac rehabilitation